Civic AI
Procurement intelligence
Federal contract award
MAVACAMTEN IS AN OUTPATIENT DRUG USED IN THE TREATMENT OF SPECIFIC TYPES OF CARDIOMYOPATHIES.
BRISTOL-MYERS SQUIBB COMPANY · Department of Veterans Affairs
- Value
- $327,534
- Start
- Jan 15, 2026
- End
- Sep 30, 2026
- Action date
- Jan 8, 2026
- PIID
- 36C26026F0137
- Status
- active
- NAICS
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- Place of performance
- MEMPHIS, TN
- Award type
- DELIVERY ORDER
Description
MAVACAMTEN IS AN OUTPATIENT DRUG USED IN THE TREATMENT OF SPECIFIC TYPES OF CARDIOMYOPATHIES.
Need modifications, related awards, and vendor peers? Open the full award workspace.